Search This Blog

Monday, July 13, 2026

BioMarin gets FDA acceptance of VOXZOGO sNDA seeking full achondroplasia approval in children

 BioMarin gets FDA acceptance of VOXZOGO sNDA seeking full achondroplasia approval in children, PDUFA action date Feb. 28, 2027

https://finviz.com/stock?t=BMRN&p=d

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.